pharmapprove.com
  • Home
  • What we do
    • Advisory Committee Preparation
    • Oral Explanation (OE)
    • Scientific Advisory Boards
    • Strategic Communications
  • About us
  • Our people
  • Our Perspective
  • Contact
  • Contact
Select Page
FDA Advisory Committees During COVID-19: When Face to Face is Not an Option

FDA Advisory Committees During COVID-19: When Face to Face is Not an Option

by Michael Piperno | Aug 7, 2020 | Featured, Insights

8 Tips to Set Your Team Up for Success By Michael Piperno There is perhaps no regulatory event as intense as an FDA Advisory Committee meeting. The stakes are high, and the applicant team has spent the last six months getting ready to deliver and defend a cohesive and...

Recent Posts

  • Proactive planning and communication with FDA is critical to regulatory success
  • Leveraging Expedited Regulatory Pathways to Optimize Drug Development
  • Team Spotlight: Dr. Frank Casty
  • FDA Advisory Committees During COVID-19: When Face to Face is Not an Option
  • Remote Q&A: Developing the perfect technique

Recent Comments

  • FDA Advisory Committees During COVID-19: When Face to Face is Not an Option - pharmapprove.com on Remote FDA Advisory Committee Meetings: Prepare for the Worst and Bring your Best

Archives

  • September 2020
  • August 2020
  • July 2020
  • April 2020
  • January 2020

CONTACT DETAILS

200 Princeton South
Corporate Center
Suite 340
Ewing, NJ 08628
USA

T. +1 609.583.1990
E. info@pharmapprove.com

Our Services

Advisory Committees
Oral Explanations (OE)
Scientific Advisory Boards
Strategic Communication

Helpful Links

Privacy Policy

Connect

  • Follow
  • Follow